Cytek Biosciences (CTKB) Change in Receivables (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Change in Receivables came in at -$9.6 million in Q1 2026, down 49.56% YoY from -$19.1 million in Q1 2025, and down 256.93% on a QoQ basis from $6.1 million in Q4 2025.
Cytek Biosciences (CTKB) Change in Receivables (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Change in Receivables data on file, last reported at -$9.6 million in Q1 2026.
- Quarterly Change in Receivables fell 49.56% year-over-year to -$9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.6 million (down 210.89% YoY) and the FY2025 annual result came in at -$368000.0, down 106.78% from the prior year.
- Change in Receivables slipped to -$9.6 million in Q1 2026, from $6.1 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $9.3 million in Q4 2024 to a low of -$9.6 million in Q1 2026.
- A 5-year average of $1.3 million and a median of $1.0 million in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables tumbled 683.33% — and 2024, when it jumped 3647.15%.
- Tracing CTKB's Change in Receivables over 5 years: stood at $8.0 million in 2022, then plunged by 103.3% to -$263000.0 in 2023, then jumped by 3647.15% to $9.3 million in 2024, then tumbled by 34.12% to $6.1 million in 2025, then plunged by 256.93% to -$9.6 million in 2026.
- The last three Change in Receivables figures came in at -$9.6 million (Q1 2026), $6.1 million (Q4 2025), and $587000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Cytek Biosciences | 602.64 Mn | 528.79 Mn | 28.34 Mn | -1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.97 Mn |
| Jun 30, 2026 | -1.97 Mn |
| Mar 31, 2026 | -9.65 Mn |
| Mar 31, 2026 | -9.65 Mn |
| Dec 31, 2025 | 6.15 Mn |
| Dec 31, 2025 | 6.15 Mn |
| Sep 30, 2025 | 587,000.00 |
| Sep 30, 2025 | 587,000.00 |
| Jun 30, 2025 | -652,000.00 |
| Jun 30, 2025 | -652,000.00 |
| Mar 31, 2025 | -6.45 Mn |
| Mar 31, 2025 | -6.45 Mn |
| Dec 31, 2024 | 9.33 Mn |
| Dec 31, 2024 | 9.33 Mn |
| Sep 30, 2024 | 6.25 Mn |
| Sep 30, 2024 | 6.25 Mn |
| Jun 30, 2024 | -5.92 Mn |
| Jun 30, 2024 | -5.92 Mn |
| Mar 31, 2024 | -4.24 Mn |
| Mar 31, 2024 | -4.24 Mn |